Similar articles for PMID: 26896160

Year	Number of Results
1950	1
1959	1
1979	1
1983	1
1985	2
1988	2
1989	2
1990	1
1991	1
1992	5
1993	2
1994	1
1995	3
1997	2
1998	2
1999	2
2000	1
2002	3
2003	1
2004	3
2005	2
2006	2
2007	8
2008	4
2009	4
2010	4
2011	5
2012	11
2013	11
2014	16
2015	10
2016	15
2017	18
2018	18
2019	15
2020	13
2021	10
2022	11
2024	0

1

Prognostic value of the bone scan index using a computer-aided diagnosis system for bone scans in hormone-naive prostate cancer patients with bone metastases.

Miyoshi Y, Yoneyama S, Kawahara T, Hattori Y, Teranishi J, Kondo K, Moriyama M, Takebayashi S, Yokomizo Y, Yao M, Uemura H, Noguchi K. Miyoshi Y, et al. BMC Cancer. 2016 Feb 19;16:128. doi: 10.1186/s12885-016-2176-6. BMC Cancer. 2016. PMID: 26896160 Free PMC article.

2

Prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancer.

Uemura K, Miyoshi Y, Kawahara T, Yoneyama S, Hattori Y, Teranishi J, Kondo K, Moriyama M, Takebayashi S, Yokomizo Y, Yao M, Uemura H, Noguchi K. Uemura K, et al. BMC Cancer. 2016 Feb 16;16:109. doi: 10.1186/s12885-016-2160-1. BMC Cancer. 2016. PMID: 26883015 Free PMC article.

3

Bone Scan Index predicts outcome in patients with metastatic hormone-sensitive prostate cancer.

Poulsen MH, Rasmussen J, Edenbrandt L, Høilund-Carlsen PF, Gerke O, Johansen A, Lund L. Poulsen MH, et al. BJU Int. 2016 May;117(5):748-53. doi: 10.1111/bju.13160. Epub 2015 Jun 13. BJU Int. 2016. PMID: 25906907

4

Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases.

Wakabayashi H, Nakajima K, Mizokami A, Namiki M, Inaki A, Taki J, Kinuya S. Wakabayashi H, et al. Ann Nucl Med. 2013 Nov;27(9):802-7. doi: 10.1007/s12149-013-0749-x. Epub 2013 Jul 5. Ann Nucl Med. 2013. PMID: 23828554

5

Bone Scan Index Is an Independent Predictor of Time to Castration-resistant Prostate Cancer in Newly Diagnosed Prostate Cancer: A Prospective Study.

Zacho HD, Gade M, Mortensen JC, Bertelsen H, Boldsen SK, Barsi T, Petersen LJ. Zacho HD, et al. Urology. 2017 Oct;108:135-141. doi: 10.1016/j.urology.2017.05.058. Epub 2017 Jul 28. Urology. 2017. PMID: 28760556

6

Assessment of bone scans in advanced prostate carcinoma using fully automated and semi-automated bone scan index methods.

Takahashi Y, Yoshimura M, Suzuki K, Hashimoto T, Hirose H, Uchida K, Inoue S, Koizumi K, Tokuuye K. Takahashi Y, et al. Ann Nucl Med. 2012 Aug;26(7):586-93. doi: 10.1007/s12149-012-0617-0. Epub 2012 Jun 29. Ann Nucl Med. 2012. PMID: 22744807

7

A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index.

Ulmert D, Kaboteh R, Fox JJ, Savage C, Evans MJ, Lilja H, Abrahamsson PA, Björk T, Gerdtsson A, Bjartell A, Gjertsson P, Höglund P, Lomsky M, Ohlsson M, Richter J, Sadik M, Morris MJ, Scher HI, Sjöstrand K, Yu A, Suurküla M, Edenbrandt L, Larson SM. Ulmert D, et al. Eur Urol. 2012 Jul;62(1):78-84. doi: 10.1016/j.eururo.2012.01.037. Epub 2012 Jan 27. Eur Urol. 2012. PMID: 22306323 Free PMC article.

8

Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model.

Gravis G, Boher JM, Fizazi K, Joly F, Priou F, Marino P, Latorzeff I, Delva R, Krakowski I, Laguerre B, Walz J, Rolland F, Théodore C, Deplanque G, Ferrero JM, Pouessel D, Mourey L, Beuzeboc P, Zanetta S, Habibian M, Berdah JF, Dauba J, Baciuchka M, Platini C, Linassier C, Labourey JL, Machiels JP, El Kouri C, Ravaud A, Suc E, Eymard JC, Hasbini A, Bousquet G, Soulie M, Oudard S. Gravis G, et al. Eur Urol. 2015 Aug;68(2):196-204. doi: 10.1016/j.eururo.2014.09.022. Epub 2014 Sep 30. Eur Urol. 2015. PMID: 25277272 Clinical Trial.

9

Prognostic value of an automated bone scan index for men with metastatic castration-resistant prostate cancer treated with cabazitaxel.

Uemura K, Miyoshi Y, Kawahara T, Ryosuke J, Yamashita D, Yoneyama S, Yokomizo Y, Kobayashi K, Kishida T, Yao M, Uemura H. Uemura K, et al. BMC Cancer. 2018 May 2;18(1):501. doi: 10.1186/s12885-018-4401-y. BMC Cancer. 2018. PMID: 29716525 Free PMC article.

10

What is the real impact of bone pain on survival in patients with metastatic hormone-refractory prostate cancer treated with docetaxel?

Oudard S, Banu E, Medioni J, Scotte F, Banu A, Levy E, Wasserman J, Kacso G, Andrieu JM. Oudard S, et al. BJU Int. 2009 Jun;103(12):1641-6. doi: 10.1111/j.1464-410X.2008.08283.x. Epub 2009 Feb 6. BJU Int. 2009. PMID: 19210673 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

185 results

Results by year